Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: Implication of tau-protein

Journal of Neural Transmission, Supplementa

Volumn , Issue 72, 2007, Pages 195-202

  Hoyer, S ^a   Lannert, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain; brain cortex; enzyme activities; glucose energy metabolism; hippocampus; sporadic Alzheimer disease; streptozotocin; tau protein

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); GUANOSINE TRIPHOSPHATE; HEXOKINASE; INSULIN RECEPTOR; LACTATE DEHYDROGENASE; OXOGLUTARATE DEHYDROGENASE; PYRUVATE KINASE; STREPTOZOCIN;

ANIMAL; ARTICLE; BRAIN; BRAIN CORTEX; DRUG ANTAGONISM; DRUG EFFECT; ENERGY METABOLISM; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; MALE; METABOLISM; NERVE CELL; RAT; SIGNAL TRANSDUCTION; TIME; WISTAR RAT;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GLUCOSE; BRAIN; CEREBRAL CORTEX; ENERGY METABOLISM; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); GUANOSINE TRIPHOSPHATE; HEXOKINASE; HIPPOCAMPUS; KETOGLUTARATE DEHYDROGENASE COMPLEX; L-LACTATE DEHYDROGENASE; MALE; NEURONS; PHOSPHOCREATINE; PHOSPHOFRUCTOKINASES; PYRUVATE KINASE; RATS; RATS, WISTAR; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; STREPTOZOCIN; TIME FACTORS;

EID: 38449106176     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-73574-9_25     Document Type: Article

References (92)

1. Banks WA (2004) The source of cerebral insulin. Eur J Pharmacol 490:5-12
2. Bergmeyer HU (1974) Methods of enzymatic analysis. 3rd edn, Vols 1 and 2. Verlag Chemie, Weinheim
3. Bigl M, Bleyl AD, Zedlick D, Arendt T, Bigl V, Eschrich K (1996) Changes of activity and isoenzyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease. J Neurochem 67:1164-1171
4. Bigl M, Brüuckner MK, Arendt T, Bigl V, Eschrich K (1999) Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm 100:499-511
5. Bigl M, Beck M, Bleyl AD, Bigl V, Eschrich K (2000) Altered phosphofruktokinase mRNA levels but unchanged isoenzyme pattern in brains from patients with Alzheimer's disease. Mol Brain Res 76:411-414
6. Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in rats after an icv injection of streptozotocin. Pharmacol Biochem Behav 44:491-494
7. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RLM, Starkey MP (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res 1127:127-135
8. 31P-NMR profiles of Alzheimer disease and multiple subcortical infarct dementia. Neurology 39:1423-1427
9. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications. Ann Neurol 57:695-703
10. Butterworth RF, Besnard AM (1990) Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab Brain Dis 5:179-184
11. Buttgereit F, Brand MD (1995) A hierarchy of ATP-consuming processes in mammalian cells. Biochem J 312:163-167
12. de la Monte S, Tong M, Lester-Coll N, Plater Jr M, Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease. J Alzheimers Dis 10:89-109
13. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS (1994) Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269:8445-8454
14. Duelli R, Schröck H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12:737-743
15. Fellgiebel A, Siesmeier T, Scheurich A, Winterer G, Bartenstein P, Schmidt LG, Müuller MJ (2004) Association of elevated phospho-tau levels with Alzheimer-typical 18F-Fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment. Biol Psychiatry 56:279-283
16. Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Zochling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105:423-438
17. Gerozissis K (2003) Brain insulin: Regulation, mechanism of action and functions. Cell Mol Neurobiol 23:1-25
18. Gibson GE, Jope R, Blass JP (1975) Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J 148:17-23
19. Giorgino F, Chen JH, Smith RJ (1992) Changes in tyrosine phosphorylation of insulin receptors and a 170, 000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: Effects of insulin and glucose. Endocrinology 130:1433-1444
20. Goldberg ND, Passonneau JV, Lowry OH (1966) Effects of changes in brain metabolism on the levels of critic cycle intermediates. J Biol Chem 241:3997-4003
21. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2006) Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlycNAcylation. J Alzheimers Dis 9:1-12
22. Grüunblatt E, Koutsilieri E, Hoyer S, Riederer P (2000) Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat. J Alzheimers Dis 9:261-271
23. Grüunblatt E, Hoyer S, Riederer P (2004) Gene expression profile in stroptozotocin rat model for sporadic Alzheimer's disease. J Neural Transm 111:367-386
24. Grüunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau-protein. J Neurochem 101:757-770
25. Gygi SP, Rochon Y, Franza BR, Aebersold R (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730
26. Hart GW (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Ann Rev Biochem 66:315-335
27. Hellweg R, Nitsch R, Hock C, Jaksch M, Hoyer S (1992) Nerve growth factor and choline acetyltransferase activity level in rat brain following experimental impairment of cerebral glucose and energy metabolism. J Neurosci Res 31:479-486
28. Hill JM, Lesniak MA, Pert CB, Roth J (1986) Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 17:1127-1138
29. Hock C, Golombowski S, Naser W, Müuller-Spahn F (1995) Increased levels of tau-protein in cerebrospinal fluid of patients with Alzheimer's disease-correlation with degree of cognitive impairment. Ann Neurol 37:414-415
30. Hoyer S (1992) Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 16:207-224
31. Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105:415-422
32. Hoyer S (2004) Glucose metabolism and insulin signal transduction in Alzheimer disease. Eur J Pharmacol 490:115-125
33. Hoyer S, Frölich L (2007) Brain function and insulin signal transduction in sporadic Alzheimer's disease. In: Sun MK (ed) Research progress in Alzheimer's disease and dementia. Nova Science, New York, USA (in press)
34. Hoyer S, Krier C (1986) Ischemia and the aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol Aging 7:23-29
35. Hoyer S, Hamer J, Alberti E, Stoeckel H, Weinhardt F (1974) The effect of stepwise arterial hypotension on blood flow and oxidative metabolism of the brain. Pflüugers Arch 351:161-172
36. Hoyer S, Lannert H, Latteier E, Meisel T (2004) Relationship between cerebral energy metabolism in parietotemporal cortex and hippocampus and mental activity during aging in rats. J Neural Transm 111:575-589
37. Kaasik AE, Nilsson L, Siesjö BK (1970) The effect of arterial hypotension upon the lactate, pyruvate and bicarbonate concentration of the brain tissue and cisternal CSF, and upon the tissue concentrations of phosphocreatine and adenine nucleotides in anesthetized rats. Acta Physiol Scand 78:448-458
38. Kadowaki T, Kasuga M, Akanuma Y, Ezaki O, Takaku F (1984) Decreased autophoysphorylation of the insulin receptor-kinase in streptozotocindiabetic rats. J Biol Chem 259:14208-14216
39. Kjäallquist A, Nardini M, Siesjö BK (1969) The regulation of extra-and intracellular acid-base parameters in the rat brain during hyper-and hypocapnia. Acta Physiol Scand 76:485-494
40. Kröncke KD, Fehsel K, Sommer A, Rodriguez ML, Kolb-Bachofen V (1995) Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotocin contributes to islet cell DNA damage. Biol Chem Hoppe-Seyler 376:179-185
41. Lackovic Z, Salkovic M (1990) Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cell destruction. Life Sci 46:49-54
42. Lai JCK, Baker A, Carlson K, Blass JP (1985) Differential effects of monovalent, divalent and trivalent metal ions on rat brain hexokinase. Comp Biochem Physiol 80:291-294
43. Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199-1208
44. Lannert H, Wirtz P, Schuhmann V, Galmbacher R (1998) Effects of estradiol (-17β) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin. J Neural Transm 105:1045-1063
45. Leong SF, Lai JCK, Lim L, Clark JB (1981) Energy-metabolizing enzymes in the brain regions of adult and aging rats. J Neurochem 37:1548-1556
46. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9:13-33
47. Lewis LD, Ljunggren B, Norberg K, Siesjö BK (1974) Changes in carbohydrate substrates, amino acids and ammonia in the brain during insulin-induced hypoglycaemia. J Neurochem 23:659-671
48. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX (2004) O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101:10804-10809
49. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the foliphenol reagent. J Biol Chem 193:265-275
50. Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E (2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 10:1083/jcb 200401085
51. Mastrogiacomo F, Bergeron C, Kish SJ (1983) Brain a-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J Neurochem 61:2007-2014
52. Maurer K, Hoyer S (2006) Alois Alzheimer revisited: differences in origin of the disease carrying his name. J Neural Transm 113:1645-1658
53. Mayer G, Nitsch R, Hoyer S (1990) Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity learning and memory in adult male rats. Brain Res 532:95-100
54. Michikawa M, Yanagisawa K (1999) Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J Neurochem 72:2278-2285
55. Mielke R, Herholz K, Grond M, Heiss WD (1994) Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 5:36-41
56. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease. Ann Neurol 42:85-94
57. Muller D, Nitsch RM, Wurtman RJ, Hoyer S (1998) Streptozotocin increases free fatty acids and decreases phospholipids in rat brain. J Neural Transm 105:1271-1281
58. Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128:199-202
59. Nitsch RM, Mayer G, Galmbacher R, Galmbacher G, Apell V, Hoyer S (1990) Impairment of cerebral glucose metabolism parallels learning and memory dysfunction after intracerebral streptozotocin. In: Maurer K, Riederer P, Beckmann H (eds) Alzheimer's disease. Epidermiology, neuropathology, neurochemistry, and clinics. Springer, Wien New York, pp 201-209
60. Norberg K, Siesjö BK (1976) Oxidative metabolism of the cerebral cortex of the rat in insulin-induced hypoglycaemia. J Neurochem 26:345-352
61. Park CR (2001) Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25:311-323
62. Perry EK, Perry RG, Tomlinson BE, Blessed G, Gibson PH (1980) Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic "compartment" of pyruvate dehydrogenase. Neurosci Lett 18:105-110
63. Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11:477-483
64. Porte Jr D, Baskin DG, Schwartz MW (2005) Insulin signalling in the central nervous system. A critical role in metabolic homeostasis and disease. From C elegant to humans. Diabetes 54:1264-1276
65. Prickaerts J, Fahring T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an icv injection of streptozotocin: a correlation analysis. Behav Brain Res 102:73-88
66. Raizada MK, Shemer J, Judkins JH, Clarke DW, Masters BA, Le Roith D (1988) Insulin receptors in the brain: structural and physiological characterization. Neurochem Res 13:297-303
67. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine. J Alzheimers Dis 8:247-268
68. Röder HM, Ingram VM (1991) Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci 11:3325-3342
69. Sacks W (1957) Cerebral metabolism of isotopic glucose in normal brain subjects. J Appl Physiol 10:37-44
70. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005-1015
71. Schechter R, Whitmire J, Holtzclaw L, George M, Harlow R, Devaskar SU (1992) Developmental regulation of insulin in the mammalian central nervous system. Brain Res 582:27-37
72. Schechter R, Beju D, Gaffney T, Schaefer F, Whetsell L (1996) Prepoinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system. Brain Res 736:16-27
73. Schönknecht P, Pantel J, Hartmann T, Werle E, Volkmann M, Essig M, Amann M, Zanabili N, Bardenheuer H, Hunt A, Schröder J (2003) Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatr Res 120:231-238
74. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB (2000) Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 24:855-872
75. Sechi LA, Griffin CA, Grady EF, Grunfeld C, Kalinyak JE, Schambelan M (1992) Tissue specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes 41:1113-1118
76. 14C) glucose in vivo in human neocortex. J Neurochem 41:1329-1334
77. Singh H, Usher S, Poulos A (1989) Mitochondrial and peroxisomal betaoxidation of stearic and lignoceric acids by rat brain. J Neurochem 53:1711-1718
78. Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidson P, Hesse C, Blennow K (1995) A population-based study of tau-protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration 4:433-442
79. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR (2006) PETof brain amyloid and tau in mild cognitive impairment. N Engl J Med 355:2652-2663
80. Sorbi S, Bird ED, Blass JP (1983) Decreased pyurvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 21:509-510
81. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051-1063
82. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signalling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 7:63-80
83. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Rev 50:536-546
84. 2 as mediator for DNA fragmentation. Diabetes 40:1141-1145
85. Terwel D, Prickaerts J, Mery F, Jolles J (1995) Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur J Pharmacol 287:65-71
86. Unger J, McNeill TH, Moxley RT, White M, Moss A, Livingston JN (1989) Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31:143-157
87. Weiss RB (1982) Streptozotocin: A review on its pharmacology, efficacy, and toxicity. Cancer Treat Rep 66:427-438
88. Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Allen AM, Mendelsohn FA (1987) Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 121:1562-1570
89. Weyne J, Demester G, Leusen I (1968a) Bicarbonate and chloride shifts in rat brain during acute and prolonged respiratory acid-base changes. Arch Int Physiol 76:415-433
90. Weyne J, Demester G, Leusen I (1968b) Brain and blood lactate during acute and prologned respiratory acidosis and alkalosis. Arch Int Physiol 76:157-159
91. Wong KL, Tyce GM (1983) Glucose and amino acid metabolism in rat brain during sustained hypoglycaemia. Neurochem Res 8:401-415
92. Zwetnow NN (1970) The influence of an increased intracranial pressure on the lactate, pyruvate, bicarbonate, phosphocreatine, ATP, ADP and AMP concentrations of the cerebral cortex of dogs. Acta Physiol Scand 79:158-166